FDA warns small biotech Ocugen of potential $10K fines for failing to post trial results
The FDA is back to warning companies of $10,000 fines for failing to report the results of clinical trials, this time going after clinical stage …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
